Climate change and respiratory diseases.
Gennaro D'Amato, Lorenzo Cecchi, Mariella D'Amato...
https://pubmed.ncbi.nlm.nih.gov/24881071Actively Recruiting
Age: 18Years +
All Genders
ID06592235
Assessment of Awareness in Individuals with Chronic Lung Disease on Climate Change, Heat Waves, Air Pollution, and Physical Activity Interaction
Led by Hacettepe University · Updated on 2024-09-19
80
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Climate change involves rising global temperatures, melting glaciers, and warmer oceans, leading to increased greenhouse gases like nitrogen and carbon dioxide that harm air and water quality. These changes contribute to extreme weather events such as heat waves, floods, and hurricanes. This research focuses on understanding how climate change and air pollution affect individuals with chronic lung diseases including COPD, asthma, bronchiectasis, and interstitial lung disease. The study aims to assess patients' awareness of climate change, heat waves, air pollution, and how these factors interact with their physical activity, anxiety, and depression levels.
CONDITIONS
Brief Title
Awareness of Individuals with Chronic Lung Disease About Climate Change, Heat Waves, Air Pollution and Physical Activity
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Being 18 years of age or older
- Having a chronic lung disease (COPD, asthma, bronchiectasis, cystic fibrosis, interstitial lung disease) and referred to the Cardiopulmonary Rehabilitation Unit for physiotherapy and rehabilitation
- Being clinically stable
- Using a smartphone with a pedometer
- Willing to cooperate with tests
- Willing to participate in the study
You will not qualify if you...
- Having had an acute exacerbation or medication change in the last month
- Having a severe cardiovascular, orthopedic, or neurological problem that may affect the tests
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - 1 day
Participants complete assessments including cognitive, anxiety and depression, quality of life, health literacy, physical activity, respiratory function, body mass index, disease-related symptoms, socio-economic status, education level, dyspnea, and comorbidity.
1 visit (in-person)
Long-term Monitoring
Duration - 1 week
Participants are monitored for environmental exposure including air temperature, humidity, wind speed, and air pollution levels relevant to their condition.
No scheduled visits; data collected remotely
Trial Site Locations
Total: 1 location
1
Hacettepe University Faculty of Physical Therapy and Rehabilitation
Ankara, Ankara, Turkey (Türkiye), 06100
Actively Recruiting
Loading map...
Research Team
A
Aslihan Cakmak-Onal, PhD, PT
E
Elif Kocaaga, MSc, PT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Extreme Weather and Climate Change: Population Health and Health System Implications.
Kristie L Ebi, Jennifer Vanos, Jane W Baldwin...
https://pubmed.ncbi.nlm.nih.gov/33406378The impact of air pollution on respiratory diseases in an era of climate change: A review of the current evidence.
Huan Minh Tran, Feng-Jen Tsai, Yueh-Lun Lee...
https://pubmed.ncbi.nlm.nih.gov/37591374The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma.
Ibon Eguiluz-Gracia, Alexander G Mathioudakis, Sabine Bartel...
https://pubmed.ncbi.nlm.nih.gov/31916265A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
M E Charlson, P Pompei, K L Ales...
https://pubmed.ncbi.nlm.nih.gov/3558716